InnoCan Pharma has began a collaboration with Tel Aviv University to develop a treatment to fight COVID-19 using cannabidiol (CBD) loaded exosomes — small structures attached to cells that are created when stem cells multiply.

The patients given the treatment will be administered CBD via an inhalation technique using those exosomes, which the company says could potentially have anti-inflammatory properties that can help in the recovery of infected lung cells.

See the original article at The Cannigma